chr1-160238649-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2
The NM_015726.4(DCAF8):c.822G>A(p.Lys274Lys) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00435 in 1,613,470 control chromosomes in the GnomAD database, including 142 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.016 ( 62 hom., cov: 33)
Exomes 𝑓: 0.0032 ( 80 hom. )
Consequence
DCAF8
NM_015726.4 synonymous
NM_015726.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.69
Genes affected
DCAF8 (HGNC:24891): (DDB1 and CUL4 associated factor 8) This gene encodes a WD repeat-containing protein that interacts with the Cul4-Ddb1 E3 ligase macromolecular complex. Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jul 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.21).
BP6
Variant 1-160238649-C-T is Benign according to our data. Variant chr1-160238649-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 788287.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.69 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0159 (2415/152330) while in subpopulation AFR AF= 0.0487 (2023/41580). AF 95% confidence interval is 0.0469. There are 62 homozygotes in gnomad4. There are 1161 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High AC in GnomAd4 at 2415 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DCAF8 | NM_015726.4 | c.822G>A | p.Lys274Lys | synonymous_variant | 5/14 | ENST00000368074.6 | NP_056541.2 | |
DCAF8 | NR_028103.2 | n.1355G>A | non_coding_transcript_exon_variant | 5/14 | ||||
DCAF8 | NR_028104.2 | n.1281G>A | non_coding_transcript_exon_variant | 4/13 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DCAF8 | ENST00000368074.6 | c.822G>A | p.Lys274Lys | synonymous_variant | 5/14 | 5 | NM_015726.4 | ENSP00000357053.1 |
Frequencies
GnomAD3 genomes AF: 0.0159 AC: 2418AN: 152212Hom.: 62 Cov.: 33
GnomAD3 genomes
AF:
AC:
2418
AN:
152212
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00833 AC: 2085AN: 250360Hom.: 39 AF XY: 0.00630 AC XY: 853AN XY: 135346
GnomAD3 exomes
AF:
AC:
2085
AN:
250360
Hom.:
AF XY:
AC XY:
853
AN XY:
135346
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00315 AC: 4605AN: 1461140Hom.: 80 Cov.: 30 AF XY: 0.00280 AC XY: 2032AN XY: 726866
GnomAD4 exome
AF:
AC:
4605
AN:
1461140
Hom.:
Cov.:
30
AF XY:
AC XY:
2032
AN XY:
726866
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0159 AC: 2415AN: 152330Hom.: 62 Cov.: 33 AF XY: 0.0156 AC XY: 1161AN XY: 74488
GnomAD4 genome
AF:
AC:
2415
AN:
152330
Hom.:
Cov.:
33
AF XY:
AC XY:
1161
AN XY:
74488
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
51
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Giant axonal neuropathy 2 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Feb 14, 2022 | - - |
DCAF8-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 12, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at